Rationale for targeting the immune system through checkpoint molecule blockade in the treatment of non-small-cell lung cancer

BACKGROUND: Treatments of non-small-cell lung cancer (NSCLC)—particularly of the squamous subtype—are limited. In this article, we describe the immunomodulatory environment in NSCLC and the potential for therapeutic targeting of the immune system through cytotoxic T-lymphocyte antigen 4 (CTLA-4) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zielinski, C., Knapp, S., Mascaux, C., Hirsch, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629900/
https://www.ncbi.nlm.nih.gov/pubmed/23393121
http://dx.doi.org/10.1093/annonc/mds647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629900/
https://www.ncbi.nlm.nih.gov/pubmed/23393121
http://dx.doi.org/10.1093/annonc/mds647

Ejemplares similares